MFSD12 and breast carcinoma: He et al. discovered that MFSD12 was increased in breast cancer cells in order to enhance the storage of lysosomal cysteine, which is released by the CTNS in order to sustain GSH levels and mitigate oxidative stress (He et al., 2023).